89 related articles for article (PubMed ID: 24023356)
1. Aberrant expression of CXCR4 and β-catenin in pancreatic cancer.
Wang Z; Ma Q; Li P; Sha H; Li X; Xu J
Anticancer Res; 2013 Sep; 33(9):4103-10. PubMed ID: 24023356
[TBL] [Abstract][Full Text] [Related]
2. Beta-catenin is a promising key factor in the SDF-1/CXCR4 axis on metastasis of pancreatic cancer.
Wang Z; Ma Q
Med Hypotheses; 2007; 69(4):816-20. PubMed ID: 17379424
[TBL] [Abstract][Full Text] [Related]
3. CXCR4 expression increases liver and lung metastasis in a mouse model of pancreatic cancer.
Saur D; Seidler B; Schneider G; Algül H; Beck R; Senekowitsch-Schmidtke R; Schwaiger M; Schmid RM
Gastroenterology; 2005 Oct; 129(4):1237-50. PubMed ID: 16230077
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of Sox7 correlates with the upregulation of the Wnt/β-catenin signaling pathway and the poor survival of gastric cancer patients.
Cui J; Xi H; Cai A; Bian S; Wei B; Chen L
Int J Mol Med; 2014 Jul; 34(1):197-204. PubMed ID: 24788044
[TBL] [Abstract][Full Text] [Related]
5. Aberrant expression of β-catenin and E-cadherin is correlated with poor prognosis of nasopharyngeal cancer.
Xu L; Jiang Y; Zheng J; Xie G; Li J; Shi L; Fan S
Hum Pathol; 2013 Jul; 44(7):1357-64. PubMed ID: 23375645
[TBL] [Abstract][Full Text] [Related]
6. SDF-1/CXCR4 promotes epithelial-mesenchymal transition and progression of colorectal cancer by activation of the Wnt/β-catenin signaling pathway.
Hu TH; Yao Y; Yu S; Han LL; Wang WJ; Guo H; Tian T; Ruan ZP; Kang XM; Wang J; Wang SH; Nan KJ
Cancer Lett; 2014 Nov; 354(2):417-26. PubMed ID: 25150783
[TBL] [Abstract][Full Text] [Related]
7. The CXCR4-CXCL12 pathway facilitates the progression of pancreatic cancer via induction of angiogenesis and lymphangiogenesis.
Cui K; Zhao W; Wang C; Wang A; Zhang B; Zhou W; Yu J; Sun Z; Li S
J Surg Res; 2011 Nov; 171(1):143-50. PubMed ID: 20462600
[TBL] [Abstract][Full Text] [Related]
8. Chemokine receptor CXCR4 expression, function, and clinical implications in gastric cancer.
Lee HJ; Kim SW; Kim HY; Li S; Yun HJ; Song KS; Kim S; Jo DY
Int J Oncol; 2009 Feb; 34(2):473-80. PubMed ID: 19148483
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic stellate cells increase the invasion of human pancreatic cancer cells through the stromal cell-derived factor-1/CXCR4 axis.
Gao Z; Wang X; Wu K; Zhao Y; Hu G
Pancreatology; 2010; 10(2-3):186-93. PubMed ID: 20484957
[TBL] [Abstract][Full Text] [Related]
10. [Significance of expression of chemokine receptor and matrix metalloproteinase in small cell lung cancer].
Li RJ; Zhao LJ; Zhan ZL; Lü X; Gong LL; Wang P
Zhonghua Yi Xue Za Zhi; 2012 Feb; 92(8):532-5. PubMed ID: 22490156
[TBL] [Abstract][Full Text] [Related]
11. [The expression and significance of SDF-1/CXCR4 biological axis in laryngeal squamous cell carcinoma and lymph node metastasize].
Zhang L; Xiong C; Wu Y; Shi H; Jing S; Song J; Zhao Z; Shan B
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Sep; 26(18):798-801. PubMed ID: 23259294
[TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of WNT pathway in surgically-treated colorectal cancer: β-catenin expression predicts for disease-free survival.
Kamposioras K; Konstantara A; Kotoula V; Lakis S; Kouvatseas G; Akriviadis E; Vrettou E; Dionysopoulos D; Krikelis D; Papadopoulou K; Charalambous E; Chrisafi S; Konstantaras C; Fountzilas G
Anticancer Res; 2013 Oct; 33(10):4573-84. PubMed ID: 24123033
[TBL] [Abstract][Full Text] [Related]
13. Involvement of E-cadherin, beta-catenin, Cdc42 and CXCR4 in the progression and prognosis of cutaneous melanoma.
Tucci MG; Lucarini G; Brancorsini D; Zizzi A; Pugnaloni A; Giacchetti A; Ricotti G; Biagini G
Br J Dermatol; 2007 Dec; 157(6):1212-6. PubMed ID: 17970806
[TBL] [Abstract][Full Text] [Related]
14. SDF-1/CXCR4 promotes F5M2 osteosarcoma cell migration by activating the Wnt/β-catenin signaling pathway.
Lu Y; Hu B; Guan GF; Chen J; Wang CQ; Ma Q; Wen YH; Qiu XC; Zhang XP; Zhou Y
Med Oncol; 2015 Jul; 32(7):194. PubMed ID: 26026718
[TBL] [Abstract][Full Text] [Related]
15. Expression of KL-6/MUC1 in pancreatic cancer tissues and its potential involvement in tumor metastasis.
Xu H; Inagaki Y; Seyama Y; Du G; Wang F; Kokudo N; Tang W
Oncol Rep; 2011 Aug; 26(2):371-6. PubMed ID: 21617869
[TBL] [Abstract][Full Text] [Related]
16. Expression patterns of alpha-, beta- and gamma-catenin in pancreatic cancer: correlation with E-cadherin expression, pathological features and prognosis.
Karayiannakis AJ; Syrigos KN; Polychronidis A; Simopoulos C
Anticancer Res; 2001; 21(6A):4127-34. PubMed ID: 11911306
[TBL] [Abstract][Full Text] [Related]
17. [Effect of chemokine stromal cell derived factor-1 and its receptor CXCR4 on the peritoneal carcinometastasis of gastric cancer].
Ding YL; Zhang JL; Tang SF; Fu QY; Li ZT
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(3):202-5. PubMed ID: 18361822
[TBL] [Abstract][Full Text] [Related]
18. [The role of stromal cell derived factor-1/CXCR4 biological axis in tumor metastasis of non-Hodgkin lymphoma].
Zhang C; Cui GH; Liu F; Wu QL; Chen Y
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):695-7. PubMed ID: 17553309
[TBL] [Abstract][Full Text] [Related]
19. Expression and the clinical significance of Wnt10a and Wnt10b in endometrial cancer are associated with the Wnt/β-catenin pathway.
Chen H; Wang Y; Xue F
Oncol Rep; 2013 Feb; 29(2):507-14. PubMed ID: 23135473
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II enhances epithelial-to-mesenchymal transition through the interaction between activated hepatic stellate cells and the stromal cell-derived factor-1/CXCR4 axis in intrahepatic cholangiocarcinoma.
Okamoto K; Tajima H; Nakanuma S; Sakai S; Makino I; Kinoshita J; Hayashi H; Nakamura K; Oyama K; Nakagawara H; Fujita H; Takamura H; Ninomiya I; Kitagawa H; Fushida S; Fujimura T; Harada S; Wakayama T; Iseki S; Ohta T
Int J Oncol; 2012 Aug; 41(2):573-82. PubMed ID: 22664794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
